pharmaphorum

OCTOBER 11, 2022

As it turned out, pharmaphorum’s launch coincided with digital’s early permeation of the healthcare industry. “[Digital] was becoming an increasing feature of our content, whether we were talking about what patients were doing in the industry, what tech companies were coming in, et cetera. Healthcare’s early digital transformation.

Pharma Companies 98

Pharma Companies Medicine Doctors Doctor 98

Pharmaceutical Technology

NOVEMBER 2, 2022

The pharmaceutical community has reached somewhat of a turning point as it commercialises a growing number of speciality medicines relying on complex new treatment pathways. Nowadays, it is an active choice many pharma companies and service providers are taking. A fresh approach.

Medicine 130

Medicine Doctors Doctor Marketing 130

pharmaphorum

DECEMBER 15, 2021

Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery. It is drug developers, patients, advocates, and caregivers in active conversations—more likely to involve clean sheets of paper than prepared scripts.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

World of DTC Marketing

APRIL 7, 2021

Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Pfizer is even taking a step further saying they no longer need a partner in developing future vaccines. Rising costs are unsustainable despite the talk about virtual visits.

Vaccination 162

Vaccination Vaccine Doctors Doctor 162

World of DTC Marketing

AUGUST 10, 2021

Source: US Library of Medicine ) There is a huge opportunity to help online health seekers cut through health misinformation. There is a HUGE opportunity for pharma companies to help sort through all the misinformation and talk to patients as people, not sales targets.

Production 180

Production Pharma Companies Doctors Doctor 180

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . According to an article by Stephens, Zachary D.,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

NOVEMBER 5, 2020

The avid blogger and passionate advocate retired from his R&D role four years ago to focus on his own health, and now works full time on making sure the patient voice is “in the room” when pharma companies make decisions. Winding road. “My I was told my policy didn’t cover it. Levelling up.

Pharma Companies 111

Pharma Companies Doctors Doctor Medicine 111

pharmaphorum

MARCH 15, 2022

The shift to virtual alone has already had a profound impact on all conference stakeholders: medical societies themselves, doctors, patients, commercial partners, and professional conference organisers (PCOs). Doctors want a choice. Part 2 will assess possible scenarios for 2022 and beyond. Lessons learnt 2020-2021. yes; and 15.7%

Doctors 105

Doctors Doctor Cardiology Allergies 105

pharmaphorum

JULY 27, 2022

It will be piloted by several DTx developers, including Mahana Therapeutics which has developed DTx for chronic health conditions like irritable bowel syndrome (IBS) and Videra Health , a specialist in online consultations and remote patient monitoring. billion in 2021.

Production 72

Production Pharma Companies Doctors Doctor 72

pharmaphorum

DECEMBER 21, 2020

Compared with many of the established names in pharma these companies are young upstarts but they have managed to achieve what other big names in the industry have failed to do and harness the power of mRNA to make medicine. They are very good doctors, scientists and entrepreneurs.

Vaccination 111

Vaccination Vaccine Doctors Doctor 111

pharmaphorum

JANUARY 24, 2022

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 million in funding from French drugmaker Sanofi.

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

pharmaphorum

NOVEMBER 30, 2022

The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine? The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

SEPTEMBER 28, 2020

The webinar discussed findings of exclusive surveys showing the continuing medical education (CME) needs of doctors and shone a light on where physicians are going for their learning needs amid the COVID-19 pandemic. Data from the US cited during the webinar showed a five-year survival rate of 34.2% for the period from 2007-2013.

Doctors 105

Doctors Doctor Pharma Companies Clinical Trials 105

XTalks

AUGUST 21, 2023

“The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. Development of medicines for rare diseases takes commitment and belief from everyone involved.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

XTalks

DECEMBER 20, 2023

These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices. Check out this article to learn about the biotech companies that went public this year.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

SEPTEMBER 16, 2021

The decision by shareholders has been greeted with consternation by health charities, public health specialists and doctors organisations, which have mounted a campaign against placing a pharma company in the hands of a big tobacco group.

Scientist 90

Scientist Production Marketing Pharma Companies 90

Drug Discovery World

APRIL 3, 2023

AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD. Additionally, the intractability of some targets with alternative ligand technologies means ligands simply cannot be developed to some targets, such as toxic or non-immunogenic targets.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

pharmaphorum

JANUARY 29, 2021

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literally cutting DNA at a specific point in the genome. The genomic medicine journey. billion in funding.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

Creogenic Pharma

FEBRUARY 17, 2021

Franchise Company. PCD Pharma Franchise in TamilNadu: Everyone demands quality medications. It is also among the fastest-growing areas and ranked among the developed countries in India. It is ranked 2nd in economic development and 3rd in Individual growth, it has also a good literacy rate. Distributor ? Wholesaler ?

Production 52

Production Sales Pharma Companies Marketing 52

pharmaphorum

AUGUST 1, 2022

Ties Kroezen, venture leader of Community Life Centers and business development manager for Philips Africa, tells us about the challenges present within the African healthcare system, solutions the company developed to help patients and providers connect, and how pharma can assist with delivering better care to African residents.

Development 78

Development Pharma Companies Drugs Life Science 78

pharmaphorum

NOVEMBER 19, 2020

By adopting a design-led, solutions-based approach to communications, companies can help healthcare professionals (HCPs) to better meet the needs of their patients through their comms, taking a scientific approach to creating clear, rational processes built on discovery, definition, development, and delivery in every aspect of healthcare.

Compliance 95

Compliance Marketing Sales Development 95

Pharmaceutical Technology

MARCH 17, 2023

At the same time, experts are saying developers in the field need to double down on securing clinical data to allow for its continued maturation. Companies are testing the use of digital platforms along with pharmacological treatments. Securing reimbursement for digital therapeutics also continues to impede its uptake.

Production 278

Production Development Pharma Companies Marketing 278

Delveinsight

AUGUST 13, 2020

The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving Celiac disease market size. Who would have thought that consumption of gluten can trigger an autoimmune disorder?

Marketing 52

Marketing Trials Antibody Pharma Companies 52

Pharma Marketing Network

JUNE 8, 2020

Don (PMN): Sure, yea patients need to be aware of their conditions and also be motivated to see their doctors for treatment right. I mean how many campaigns was I involved with, be it commercials or ads, like “Ask your doctor what’s right for you.” Pharma marketers and healthcare marketers are looking to reach these patients directly.

Doctors 40

Doctors Doctor Clinical Trials Clinical Trials 40

pharmaphorum

SEPTEMBER 1, 2020

Whilst the scientific revolution of the 17th century had spread ideas of rationalism and experimentation, and the industrial revolution had transformed the production of goods in the late 18th century, the marrying of the two concepts for the benefit of human health was a comparatively late development.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

pharmaphorum

AUGUST 9, 2022

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient groups. An area that offers hope to accelerate an understanding of cancer and speed up drug development is artificial intelligence. Patient focus.

Drugs 111

Drugs Doctors Doctor Pharma Companies 111

Cloudbyz

SEPTEMBER 25, 2020

HEPAprint, MEDIKURA, Navro, Embleema & Cloudbyz develop 5 top solutions to watch out for. Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups working on solutions for the pharma sector. Clinical trials play a pivotal role in drug development. HEPAprint – Adverse Drug Reaction (ADR).

Pharma Companies 52

Pharma Companies Big Data Drugs Clinical Trials 52

World of DTC Marketing

JANUARY 31, 2021

Smaller biotechs that are developing new drugs usually don’t have the resources to take new drugs to market. The venture capitalists funding them are looking for a big payday when a pharma company acquires them. The cost is estimated to be in the billions.

In-Vivo 187

In-Vivo Generic Drugs Gene Therapy Drugs 187

pharmaphorum

JULY 9, 2021

Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. After searching, Parkes and Hayee discovered that there weren’t any existing tools that fit their needs – so they decided to develop a solution themselves.

Doctors 69

Doctors Doctor Marketing Development 69

World of DTC Marketing

JUNE 22, 2021

(New York Times ) If you spend any time reading pharma PR releases, you’ll see over and over again corporate managements stressing the importance of the shareholder. When a new drug is derailed the first thing that pops out is the effect on the company’s stock price, not patients. It is not for the profits.

Drugs 156

Drugs Pharma Companies Medicine Doctors 156

World of DTC Marketing

MAY 24, 2021

The list of pharma CEO salaries is enough to make one ill with a sickness that prescription medicine can’t cure. Despite advances in diagnosis and treatment, doctors still have much to learn about what triggers a cell to become cancerous and why some people who have cancer do better than others.

Drugs 193

Drugs Vaccination Vaccine Pharma Companies 193

pharmaphorum

MARCH 12, 2021

As moderator Gareth Powell – business development officer, patient engagement and clinical development service project lead at the NIHR – noted, the Institute has seen fantastic feedback from patients on the increased use of virtual engagement over the course of pandemic. “The We need to talk to the patients at that point.

Trials 132

Trials Research Pharma Companies Clinical Trials 132

XTalks

OCTOBER 15, 2021

Fittingly, it was also used to develop the vaccine against cervical cancer. Lacks’ cells demonstrated unique properties as they were able to proliferate extensively, leading to development of the immortal HeLa cell line. The name of the HeLa cells was derived from the first two letters of Henrietta Lacks’ first and last names.

Vaccination 105

Vaccination Vaccine Gene Mapping Doctors 105

pharmaphorum

OCTOBER 10, 2022

In lung cancer, early detection is particularly important, as symptoms typically do not appear until the disease has already reached an advanced stage of development. TLHCs are designed to catch lung cancer during the early stages of development in asymptomatic patients with a high risk of developing the disease.

Development 98

Development Research Marketing Life Science 98

The Pharma Data

NOVEMBER 16, 2020

It would be easier for patients, who wouldn’t have to juggle fistfuls of daily medications, and for doctors who’d only have to write one prescription. 13 in the New England Journal of Medicine. of those who took aspirin alone developed heart-related illness, compared to 4.7% ” Yusuf said. who took the placebo.

Doctors 52

Doctors Doctor Cardiology Pharma Companies 52

XTalks

OCTOBER 1, 2020

And although academia and industry have often been pitted against each other in the realm of scientific discovery and development, there may be more similarities and synergies between the two than we may think. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

Scientist 52

Scientist In-Vitro Research Life Science 52

Drug Discovery World

AUGUST 16, 2022

Anita Ramanathan examines the importance of inclusivity and diversity throughout the drug discovery and development process. . These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery.

Research 52

Research Clinical Trials Clinical Trials Trials 52